Login
Subscribe
Sanger Institute Accused of Misusing African DNA Samples
Sanger Institute Accused of Misusing African DNA Samples
Whistleblowers allege the institute intended to commercialize a research tool based on the material, a violation of agreements with African scientists who collected the sequences.
Whistleblowers allege the institute intended to commercialize a research tool based on the material, a violation of agreements with African scientists who collected the sequences.
commercialization, genetics & genomics
TS Picks: CRISPR Patent Edition
Kerry Grens | Jan 5, 2016 | 2 min read
A challenge to the first CRISPR patent just got teeth.
Competition for CRISPR Commercialization
Kerry Grens | May 1, 2014 | 1 min read
Researchers stake their proprietary claim on the genome-editing technique.